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Abstract
Background: While evaluation of ethical aspects in health technology assessment (HTA) has gained much attention
during the past years, the integration of ethics in HTA practice still presents many challenges. In response to the
increasing demand for expansion of health technology assessment (HTA) methodology to include ethical issues
more systematically, this article reports on a multi-stage study that aimed at construction of a framework for
improving the integration of ethics in HTA.
Methods: The framework was developed through the following phases: 1) a systematic review and content
analysis of guidance documents for ethics in HTA; 2) identification of factors influencing the integration of
ethical considerations in HTA; 3) preparation of an action-oriented framework based on the key elements of
the existing guidance documents and identified barriers to and facilitators of their implementation; and 4) expert
consultation and revision of the framework.
Results: The proposed framework consists of three main components: an algorithmic flowchart, which exhibits the
different steps of an ethical inquiry throughout the HTA process, including: defining the objectives and scope of the
evaluation, stakeholder analysis, assessing organizational capacity, framing ethical evaluation questions, ethical analysis,
deliberation, and knowledge translation; a stepwise guide, which focuses on the task objectives and potential
questions that are required to be addressed at each step; and a list of some commonly recommended or
used tools to help facilitate the evaluation process.
Conclusions: The proposed framework can be used to support and promote good practice in integration of
ethics into HTA. However, further validation of the framework through case studies and expert consultation is
required to establish its utility for HTA practice.
Keywords: Ethics, Health technology assessment, Framework, Model, Tools
Background
There has been an increasing awareness of the need to
incorporate ethics into the health technology assessment
(HTA) process. This need is a consequence of the recog-
nition that addressing moral and ethical issues can
increase transparency and accountability of the HTA
process and lead to better informed healthcare decisions
[1]. As a result, HTA producers and decision-makers are
increasingly more interested in considering contextual
normative issues and value judgments, in addition to the
results of clinical and economic evaluations in HTA.
Despite its importance, integration of ethical aspects
into HTA remains challenging for several reasons. One
of the key challenges is the plurality of ethical methods
that need to be understood by HTA professionals in
order to be applied appropriately [2, 3]. Our systematic
review of existing guidance documents for ethical
analysis in HTA suggested that methods proposed to
address ethical issues differ considerably in terms of
philosophical approach, structure, and comprehensive-
ness, and that there is no “one right way” to evaluate
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ethical considerations around healthcare technologies
[4]. Another challenge is that HTA agencies too often
fail to adopt the existing ethical guidance documents
because most of the guidelines tend towards complexity
and call for expertise, time and other resources that
might not exist in their organizations. A recent survey of
international HTA agencies revealed that only in 15 % of
the participating agencies, ethical evaluations were
typically performed by individual, mainly external, ethi-
cists or multi-disciplinary teams including ethicists. The
majority of the surveyed HTA organization relied on
non-ethicist HTA professionals to conduct ethical evalu-
ations, when required [2].
We believe if HTA professionals are expected to take
part in ethical evaluations, they need a systematic ap-
proach that places greater emphasis on the process and
steps required for merging ethics review activities with
traditional HTA. This systematic approach should help
HTA practitioners better understand the ethical evalu-
ation process, use relevant ethics tools and seek appro-
priate expert guidance in answering ethical questions, if
needed.
A number of existing guidance documents come
closest to fulfilling this need. However, they rarely focus
on the operationalization of their proposed approaches.
For example, the ethical evaluation component of the
European network for HTA (EUnetHTA)’s Core model
[5], is a comprehensive document that provides a
checklist of questions covering ethical issues related to
the technology and the HTA process, describes com-
monly used methods to answer the questions, and
proposes a standardized reporting structure. Likewise,
the guidelines developed by a number of European HTA
agencies, including the Austrian [6], Danish [7], French
[8], German [9], Norwegian [10], Spanish [11], and
Swedish [12] agencies, promote similar systematic ap-
proaches to integrating ethics into the HTA process.
However, all of these guidance documents provide few
details on what is needed to be done in order to imple-
ment the proposed methodology in a routine HTA en-
vironment. A further step has more recently been taken
by the Swedish Council on HTA to provide a framework
that takes into account not only the nature of the HTA
process, but also organizational, financial and regulatory
elements, as well as the availability of ethical expertise
[13]. This framework that focuses on the identification
and prioritization of ethical considerations in HTA pro-
vides only a brief description for operationalizing the
ethics review process.
For HTA researchers with limited experience of
performing ethical evaluations, there is still a need for a
procedural guidance which would enhance their under-
standing of how an ethics review can take place during a
HTA process and to aid them in incorporating ethical
evaluation steps into a typical HTA plan. The aim of this
paper is to fill this gap by offering a structured action-
oriented framework and a list of literature-driven sup-
porting tools. It should be noted that we do not intend
to “reinvent the wheel” by proposing an alternative ap-
proach to substitute existing ethical inquiry methods.
Rather, our study is intended to provide a process-based
framework that encompasses a range of evaluative ac-
tions provided by other ethical guidelines for HTA in
order to illustrate and describe the steps that are ex-
pected to be taken by a HTA team in evaluation of eth-
ical considerations. We believe such a framework would
allow HTA producers not only to understand the ethics
review process, but also to make use of ethics in their
assessments, by identifying interconnections and over-
laps between ethics and other domains of HTA. Our
framework also brings together the procedural steps and
potentially helpful tools to provide more flexibility to the
ethical evaluation process in HTA and increase its
applicability.
The remainder of this paper is organized as follows:
we begin with a description of our multiphase research
methodology. Then, we introduce our stepwise frame-
work and explain some important considerations which
should be taken into account at each particular step.
Next, we introduce a number of the most commonly
used tools in ethical evaluation. Finally we offer fur-
ther discussion of our proposed framework and draw
conclusions.
Methods
We initially performed a systematic review of the litera-
ture, published up to October 2013, with the purpose of
identifying and mapping existing frameworks for ethics
in HTA and methodological guidelines from national
and international HTA agencies. The review identified
21 methodological articles and 22 HTA guidelines of
varying complexity and scope. Data was abstracted,
through content analysis, on methodological features of
the identified guidance documents, particularly their
areas of focus, theoretical foundation, analytical ap-
proaches, supporting tools, and required expertise. More
details about this phase of research have been published
elsewhere [4].
Then, to identify factors that are likely to influence the
ethics review process, we conducted a comprehensive
search in the literature to create a list of main barriers
and facilitators of ethical evaluation in HTA. In addition,
we performed a survey of the main HTA producing
agencies throughout the world to learn about their expe-
riences, methodological preferences, and their percep-
tions of the key barriers and enablers to incorporation of
ethics in HTA. Ethics approval for the survey was
granted by the Hamilton Integrated Research Ethics
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Board at McMaster University (REB 13-103). Informed
consent was obtained using a recruitment email which
described the aims of the study and notified participants
that completion of the survey implied consent to partici-
pate in the survey. Therefore, a separate informed con-
sent form was not required. The findings of the
literature review and the survey are published in detail
elsewhere [2].
The next stage was to draft a framework based on op-
erational features of the identified guidance documents,
as well as practical barriers to avoid and enablers to
encourage in performing an ethical evaluation. We
used data from the guidance documents included in
our systematic review [4] to generate a comprehensive
list of main elements and sub-elements that needed
to be considered in an ethical evaluation and identify
the common elements. The following a priori categor-
ies were utilized to group action items: scoping, data
collection, analysis, and knowledge translation. How-
ever, as the analysis progressed, some preliminary cat-
egories were combined and further categories were
added. The identified barriers and facilitators were
used for further defining and customizing action cat-
egories and their related task statements [2]. The
process was continued until seven final action cat-
egories were established: defining the objectives and
scope of the evaluation, identifying stakeholders, assessing
organizational capacity, framing ethical evaluation ques-
tions, ethical analysis, deliberation, and knowledge ex-
change or translation.
We generated a separate list of commonly recom-
mended tools, which were identified in our systematic
review [4], and examined all in relation to their applica-
tion and appropriateness for each procedural step. Add-
itional ethical tools were identified through targeted
searches in the literature and consultation with subject
matter experts. Finally, a summary table consisting of a
brief description of the identified tools as well as some
of the strengths and weaknesses of each tool was
generated.
Results
Our proposed framework consists of an algorithmic
flowchart that illustrates a set of steps for operation-
alizing ethical evaluation throughout various stages of
the HTA process; and a stepwise guide, which breaks
down each step into individual task objectives and
suggests some questions that need to be addressed at
each step in order to complete the suggested tasks.
To help facilitate the proposed evaluation tasks, a list
of some commonly recommended or used tools is
also provided, along with a brief description of their
strengths and weaknesses. The Framework compo-
nents are summarized below.
The algorithmic flowchart
As illustrated in Fig. 1, our stepwise flowchart organizes
the actions required for an ethical evaluation practice
into seven main steps and four conditional steps that
allow for revisions and improvements within and across
the main steps of the evaluation process. Although in
this figure, progression from one step to another is
shown to be linear, it is important to note that in real
practice ethical evaluation activities can often occur sim-
ultaneously or iteratively.
The stepwise guide
To make the framework useful for HTA practitioners,
we have attempted to operationalize it into a guide,
which can be seen in Table 1. The guide includes a non-
exhaustive list of tasks and related questions which are
drawn from our systematic review of ethical guidelines
for HTA [4], input from experts in the fields of HTA
and ethics (n = 6), and from our study of barriers and fa-
cilitators of ethical evaluation in HTA [2]. As with many
ethics frameworks in other contexts, this guide is
intended to aid HTA practitioners in identifying key
steps that should not be overlooked, while also helping
them to think about possible action items.
Step1. Defining the objectives and scope of the evaluation
Before starting an ethical assessment, it should be en-
sured that the objectives of both the overall HTA, to
which the ethical evaluation will be incorporated, is set.
In doing so, the role of ethics should not be over- or
under-estimated. Rather, the scope and aims of ethical
evaluation should be proportional to the candidate tech-
nology and the context [14]. A careful consideration of
potential ethical issues around the primary motivations
for conducting an HTA is also required at the scoping
step, such as special interests of certain stakeholders in
the assessment or external pressure from authorities,
manufacturers, and patient groups. Then, as with any
other evaluation process, ethical assessment should
begin with an exploratory phase to identify the existing
knowledge base surrounding the technology of interest
such as technological aspects, modes of application,
range of possible clinical indications, safety issues, as
well as the therapeutic, economic and organizational im-
pacts of the technology. Identifying the purpose of the
ethical evaluation is the next essential task, as it will feed
into the type of research questions, study design, and
choice of ethical analysis approaches.
Step2. Stakeholder analysis
Given the importance of stakeholder interests and values
in an ethical evaluation and their influences over poten-
tial decisions, it is good practice to conduct a stake-
holder analysis during the defining and scoping phase to
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make sure that values and preferences of potential stake-
holders are effectively included in the ethical analysis.
Nonetheless, stakeholder analysis can be undertaken
throughout all steps of ethical evaluation.
During the scoping phase, potential stakeholders can
be identified through brainstorming, collecting and ana-
lyzing quantitative or qualitative information, and asking
identified stakeholders who they would suggest as rele-
vant stakeholders for the technology of interest. A typ-
ical stakeholder analysis involves assessing the interests
of the identified key stakeholders, such as patients,
healthcare providers, decision makers, family members
and the general public in the candidate technology;
assessing their importance and level of influence over
the HTA process and decision-making; determining who
stands to benefit and who stands to lose if the candidate
technology is introduced, in what ways and to which
extent; and identifying the most appropriate ways to en-
gage stakeholders [15, 16]. Some useful tools for stake-
holder analysis are introduced in Table 2.
Step3. Assessing organizational capacity
The following resources are necessary in performing an
ethical evaluation: a person with a strong educational
background and experience in applied ethical theory,
sufficient financial resources and time for conducting
the evaluation, and the capacity for training, if needed.
Therefore, it is important to assess the level of
organizational readiness along each of these dimensions
in order to balance available resources with the require-
ments of ethical evaluation.
It must be ensured that sufficient knowledge, experi-
ence, and skills exist in the organization to collect ethics-
related data and to perform a comprehensive ethical ana-
lysis for several reasons. Firstly, since ethical evaluation is
an approach which deals with norms and values, conduct-
ing such an evaluation would not be possible without a
reasonable amount of knowledge of ethical theories and
principles. Secondly, because the scope of ethics literature
is wide and can include theory as well as both quantitative
and qualitative study results, HTA practitioners involved
in ethical evaluations should be able to effectively appraise
ethics literature and reflect on the collected information.
Thirdly, a well-performed ethical analysis uses moral rea-
soning rather than merely describing facts and values.
Hence, the rigour of ethical reasoning is usually
dependent on how skillfully the analysis has been per-
formed. Furthermore, the capacity in methodologies
a. b. c.
Fig. 1 Algorithmic flowchart for ethical evaluation in HTA
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Table 1 Stepwise guide for the ethical evaluation process in HTA
Steps Evaluative tasks Potential questions
1) Defining the objectives and scope of
the evaluation
□ Clarify the objectives and the scope of
the HTA project
- What is the purpose of the HTA project (e.g., providing
input for decision-making, formulating recommendations
for practice guidelines, serving academic purposes)?
- What is the rationale for the assessment of the technology
(e.g., changing current practice, uncertainty/disagreement
about benefits or risks of the technology)?
- What are the information needs of potential users of the
HTA findings?
□ Consider ethical issues around the HTA
project itself
- Why is the assessment undertaken? Who has requested it?
- Is there any special interest in the assessment or pressure
from authorities, manufacturers, patient groups, etc.?
- Is there any conflict-of-interest concerns?
□ Identify existing knowledge base about
the technology
- Are there any characteristics of the technology that may
raise ethical concerns (e.g., risk/benefit profile, utilization in
vulnerable populations, access issues, modes of application)
- What is the current practice?
- What is the desirability of the technology (e.g., positive or
negative utility values, QALYs)
- What are the costs and organizational requirements for
the implementation of the technology?
□ Specify the objectives of ethical
evaluation
- What the HTA team/organization intends to achieve by
performing and ethical analysis (e.g., a description of
ethical issues around the technology, identifying and
resolving uncertainties around implementation of the
technology by learning about stakeholder values and
societal interests or through philosophical reflection)?
2) Identifying stakeholders □ Identify potential stakeholders; engage
key stakeholders to identify other
stakeholders
- Who (potential groups or individuals) might affect or be
affected (benefit/loose) by the introduction of the
technology (e.g., decision-makers, manufacturers,
healthcare providers, societal actors, patients and
their families)?
□ Identify the ways in which the above
groups may be affected by the
implementation of the technology
- What are the potential consequences of implementing the
technology on disadvantage groups (access, equity, etc.)?
- What are the potential consequences of implementing
the technology on other stakeholders?
□ Identify the ways in which the above
groups may affect the implementation
of the technology
- What are the known interests of stakeholders in the
implementation of technology?
- What opportunities (level of power) do stakeholders
have to get involved in making decision about the
implementation of the technology?
3) Assessing organizational capacity □ Define key requirements - What are the policy directions and priorities of the HTA
organization and how might these influence evaluation
of ethical considerations?
- Is there a shared understanding of objectives and
outcomes of HTA and ethical evaluation?
- Are the opinion leaders in the organization supportive
of integrating ethics in HTA?
- Do the project timelines allow enough time for the
completion of an ethical evaluation?
- Are there any feasibility issues regarding ethicist
involvement or stakeholder engagement?
- Does the organization have any previous experience
with ethical evaluations?
□ Establish a team consisting of ethical
expertise, HTA practitioners with
experience in evaluation of normative
aspects of healthcare technologies,
and relevant stakeholders (when needed)
- Is the ethical expertise available in house? If not, are any
external ethicists available to be recruited for the purpose
of this evaluation?
- Are there sufficient staff members with required
characteristics (knowledge, skills and attitude) available
to take part in the ethical evaluation?
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Table 1 Stepwise guide for the ethical evaluation process in HTA (Continued)
4) Framing ethical evaluation questions □ Recognize potentially relevant ethical
problems and solutions that may arise
from the introduction of the technology
- Is there any potential conflict between the technology
and basic human rights, social and cultural values,
patient’s autonomy, etc.?
- What are the moral characteristics of the technology
(e.g., risk/benefit profile, health improvement at the
individual and society levels)?
- Does implementation the technology require any life
style modifications?
- What are the long term effects of the technology on the
users, their family members, and society (e.g. psychological
impact, discrimination)?
□ Map the current practice from an
ethical perspective
- What are the key problems with the current use of
technology (e.g., costs, equity problems, privacy, misuse
of technology, freedom)?
- What are the affected groups’ perceptions about the
current practice?
□ Identify sets of governance steps that
might be necessary to resolve potentially
relevant issues
- What solutions have been proposed to deal with the
identified ethical problems?
- How effective these solutions have been reported to be?
□ List ethical issues around the technology - Have I been able to identify any ethical issues around the
technology (e.g., outcomes of medical choices, society’s
access to the technology, ethically controversial situations
at political or local levels, and ethically challenging
situations at societal or healthcare system levels)?
□ Justify what issues should be included
in the ethical analysis, and why
- Which of the identified ethical issues are more relevant
to the HTA project’s goal, and why?
- Which of the identified ethical issues are more important,
and why?
□ Use dialogues and/or other deliberative
methods for input seeking from ethical
and technical experts as well as potential
users, if necessary
- Has the plausibility of the identified ethical issues been
stablished or discussed?
- What insights are available from experts or stakeholders
to aid in finalizing ethical evaluation questions?
5) Ethical analysis □ Choose an appropriate methodology
to address identified ethical dilemmas
- What methodologies are described in the literature or
have been employed by others to study similar problems?
- What theoretical paradigm is chosen by the research
team to inform the ethical evaluation (utilitarian theory,
deontological ethics, virtue ethics, etc.)?
- What is the most practical and reliable approach to
collect and analyze ethical data, considering the purpose
of analysis, available expertise and other resources and
feasibility of stakeholder engagement (e.g., empirical
approach [using quantitative data], philosophical
approach [using ethical theories and principles], narrative
approach [using facts, value judgments, and stakeholder
preferences], or a mixed approach)?
□ Justify the choice of method - What theoretical paradigm best fits the evaluation
questions? and why?
- How the selected approach might be helpful in answering
evaluation questions?
□ Review existing information and acquire
additional relevant information through:
- An extensive search in quantitative and
qualitative literature
- Deliberative methods
- Have adequate data been collected to serve the purpose
of the ethical analysis?
- What information is available in the literature about
ethical, social or legal impact of the technology?
- Is there any (retrospective, current or futuristic) information
available on the use of the technology in different social
and cultural contexts?
- What arguments are available in the literature in favour of
or against the technology?
- What are the stakeholders’ values and preferences?
- What controversies and potential conflicts exist at the
local, societal and political levels around implementation
of the technology?
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Table 1 Stepwise guide for the ethical evaluation process in HTA (Continued)
□ Ensure data from all sources are
considered for analysis
- Has data from all possible sources collected for the ethical
analysis (e.g., quantitative and qualitative evidence,
stakeholder hearings, and expert opinion)?
- Is triangulation of data sources possible?
□ Examine the collected data for logic
and coherence, validity and reliability
- What is the level of internal consistency of data? Is the
collected data reliable?
- Is there any self-contradiction or incoherence in the
collected data? Does a fundamental logic exist among
the collected facts and values?
- What are the e factors that could influence generalizability
of the evaluation results?
□ Synthesize and integrate collected data
(facts and values) into ethical arguments
- Apply the principles of biomedical ethics
- Perform philosophical arguments
on the ethical questions from the
perspective of ethical theories
- Reflect on possible solutions
- Does the implementation or use of the technology
challenge the basic principles of biomedical (e.g.,
beneficence, non-maleficence, autonomy, justice,
vulnerability,)
- What are the key arguments in favour of using the
technology?
- What are the key arguments against implementation of
the technology?
- Are clinical or economic benefits of the technology
justifiable from the chosen (various) ethical perspective(s)?
- Are the arguments sound and clear?
- What are the possible options for acting, and their
consequences?
□ Acknowledge your own values and
philosophical interest
- What is your position (perspective) on the matter?
- How would you interpret the data, if you were in the
stakeholders’/policy-makers’ shoes?
- How confident are you that your position will remain
the same in the matter over time?
6) Deliberation □ Discuss the results of evaluation with
an expert group to assess their
relevance and completeness
- What do the experts have to say about the relevance of
the collected data?
- Do the experts have any suggestions as to what other
sources of relevant information are available?
□ Choose an appropriate method to
discuss the results of ethical analysis
with relevant stakeholders to seek their
feedback on the results
- Who are the appropriate stakeholders to take part in or
provide feedback on the analysis?
- What are alternative sources of values for interpreting
ethical analysis findings?
- What are the ways that encourage identified stakeholders
to provide required information.
- What are the main concerns, preference, and emergent
needs of stakeholders?
- To what extend the stakeholder engagement activities
have captured required information?
□ Seek additional expert insight, if
necessary, to ensure about the
plausibility of the produced results
during stakeholder hearings.
- Is it required/worth to engage a group of experts in a
discussion of the ethical evaluation results?
- Do you have any specific questions/uncertainties which
you would like the experts to address?
7) Knowledge exchange/translation □ Refine your target audience that might
be interested or may benefit from the
results of HTA
- Who is the target audience (e.g., policymakers, healthcare
providers, patient groups, academic audience)?
□ Refine information needs of your
target audience
- What are the ways in which the report will be used
(e.g., direct use of knowledge for problem-solving,
conceptual use of knowledge for perception-shifting or
understanding, political use of knowledge for supporting
or challenging policy decisions)?
□ Structure a presentation format to
address the information needs of target
audience
- How should the evaluation results be made available to
users (in terms of content and format)?
□ Report the results of ethical analysis in
a transparent and effective manner
- Are the criteria and logic for the choice of methodology
and selection of stakeholders disclosed?
- Are the identified gaps in the literature, concerning
ethical issues and values, addressed?
- Are all favorable and non-favorable arguments reported?
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associated with ethical analysis through public dis-
course is often lacking in some HTA organizations
[17]. Therefore, to get involved in public participatory
processes, HTA professionals might need to acquire a
range of new skills in different methods of public
engagement before getting involved in such research
activities [14, 18].
Step4. Framing ethical evaluation questions
Recognition of existing ethical dilemmas or the ones that
are perceived likely to emerge after implementation of
the technology (hypothetical dilemmas) is essential for the
formulation of ethical questions that need to be answered.
Identification of the existing ethical issues that could be
resolved through the introduction of the technology
should also be accounted for. Zydziunate et al. [19] sys-
tematically reviewed ethical dilemmas that might affect
decision-making within health care systems and suggested
that ethical dilemmas in healthcare might happen in insti-
tutional, local or national levels. The review listed the fol-
lowing terms that had been commonly used in defining or
discussing ethical dilemmas: “continuing balancing” be-
tween health care needs and budgets, “result of resource
allocation”, “gap between professional obligations and pos-
sibilities”, “ethically controversial situation”, “concern
about interactions”, “outcome of medical choices”, “con-
cern about society’s access to healthcare resources”, and
“ethically difficult or ethically challenging situation”.
In practice, it might not always be necessary to make a
comprehensive list of existing ethical conflicts or contro-
versial issues through a systematic inquiry. However, it is
important to discuss and specify which of the recognized
ethical considerations and arguments are more relevant
to the assessment and provide a justification for why
these could be relevant. One familiar example is the di-
lemma that might arise in situations involving genetic
testing technologies. Genetic test results, by nature, can
reveal aspects of the tested individual’s susceptibility to
health problems (potential for stigmatization or discrim-
ination). In addition, they may have implications on the
blood relatives of the tested individual, who might also
request to know their family member’s genetic test re-
sults (potential for information abuse or intrusion of
privacy). These aspects of the technology should be
explored and discussed while framing the ethical evalu-
ation questions. At this phase of evaluation, a priority
should be assigned to ethical questions that may have
greater implications on decision making. However, the
HTA team must allow flexibility for adding questions
during the ethical evaluation process.
Step5. Ethical analysis
As it was previously mentioned, the present framework
does not aim to provide instructions on how to perform
an ethical analysis, but rather assumes that HTA team
members who are responsible for the analysis of ethics
data have the knowledge and skills to take on this im-
portant task. Ethics expertise can be critical at this step,
depending on the type of the assessment. A normative
(principle- or theory-based) evaluation should generally
be performed with the help of experts with knowledge
in ethical theory. In participatory or interactive assess-
ments, where expert and lay opinions are considered
equally valuable, ethicists can play an active role by pro-
viding rationale for potentially useful analytical ap-
proaches, scientific and theoretical inputs to stakeholder
and public debates and assisting stakeholders in reaching
a consensus [14]. In sensitive topics, it may be desirable
to seek discussion from more than one ethicist. Other
HTA practitioners (non-ethicists) can also have a role,
although necessarily limited, in ethics review and ana-
lysis (e.g., helping with formulating ethical questions and
searching for potential solution through systematically
identifying and summarizing ethics-related data, helping
with participatory research, etc.).
Our systematic review identified multiple guidance
documents for the analysis of ethical data. The identified
methodological approaches vary in their goal, philo-
sophical approach, structure, and comprehensiveness.
Traditional approaches consist of making ethical issues
explicit by identifying facts and values, setting out
arguments, providing reasons and justifying potential de-
cisions through moral principles and theories (e.g., prin-
ciplism, deontology, casuistry, and axiology). Deliberative
approaches, on the other hand, advocate participatory and
interactive approaches as complementary methods to
traditional normative reasoning (e.g., wide reflective equi-
librium, actor-network theory, interactive HTA, and social
Table 1 Stepwise guide for the ethical evaluation process in HTA (Continued)
- Are anticipated changes that may follow from the
implementation of the technology discussed?
- Are the findings summarized and the most important
value issues highlighted?
□ Integrate knowledge translation in all
steps of the assessment
- Has there been an integrated flow of information
among team members working on different aspects
of the technology (clinical, economic, ethical, social,
legal, and organizational aspects) throughout the
HTA process?
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Table 2 Commonly used tools for ethical evaluation in HTA
Tool Description Strengths Challenges References
A. Ethics literature review and appraisal
Methodologies for the search and
retrieval of information on ethical
issues in HTA
Methodological approaches for the systematic
retrieval of ethical information are discussed in
two articles. These articles provide
recommendations for good practice in selection
of sources of ethical information, designing and
executing ethics-specific search strategies,
quality check of search results, and reporting
information retrieval process.
Encourages a separate literature search
relevant to ethical questions, using the
common retrieval framework for
effectiveness assessments.
The proposed search terms or strategies
might not be sufficient for retrieval of all
relevant ethical issues. Additional targeted
searches might be necessary.
[31, 32]
Tools for critical appraisal of
empirical ethics research
An article by Strech discusses the appropriate
criteria for appraisal of empirical research
required for ethical reasoning. He suggests four
appraisal criteria related to the relevance of
study questions, selected outcomes and
measure, study design and generalizability of
study results.
Addresses some important challenges of
considering empirical data in ethical
analysis.
No detailed guidelines or case studies are
provided for how to apply the appraisal
criteria.
[33]
Mertz et al propose a set of structured quality
criteria which can be used as a checklist to
guide empirical ethics researchers and
appraisers in the following four domains:
research methodology, scientific and social
relevance of the research project,
interdisciplinary research practice, and research
ethics.
Designed based on an in-depth analysis of
existing empirical ethics research and the
opinion and experience of experts in the
field of medical ethics.
The practicality of the criteria is not tested
in real life empirical ethics research practice.
[34]
A tool for critical appraisal of
normative medical ethics literature
McCullough et al offer a tool to help clinicians
(particularly obstetrician/gynecologists) in critical
appraisal of normative bioethics literature. The
tool incudes four questions about the focus of
the study, validity and soundness of the study
results, as well as their implication and
usefulness in clinical practice.
Designed based on the standards of critical
appraisal of argument-based ethics and
evidence-based medicine.
Judgment about the validity and quality of
ethical analyses and arguments requires
some level of knowledge about ethical
reasoning. This might not be an easy task
for the target audience of the tool, i.e.,
physicians.
[35]
Guidelines for systematic reviews of
ethical evidence
Strech e t al propose a 7-step approach for
systematic reviews of empirical bioethics
literature, The stepwise process involves
definition of review questions, development
and execution of search strategies, assessment
of relevance and quality of identified studies,
and analysis and presentation of data.
Practical recommendations are provided for
each step.
The application of the proposed approach is
illustrated with an example.
The proposed search algorithms are not
definitive and might need some
modifications depending on the context
and review questions.
Data analysis and presentation may require
some level of knowledge and skills in
synthesis of qualitative data.
[36]
Strech and Sofaer also offer a methodology for
systematic reviews of non-empirical reason-
based bioethics literature. Their model provides
instructions for formulation of review questions
and study selection criteria, identifying eligible
literature, data extraction and synthesis, as well
as presentation of the review results.
Structured based on the common steps of a
systematic review process.
Provides a detailed description of
operational steps, and examples of how to
apply the model in practice.
Performing a “systematic” review based on
this model might be time-consuming.
This type of review requires some level of














Table 2 Commonly used tools for ethical evaluation in HTA (Continued)
B. Stakeholder analysis
Stakeholder Power/Interest grid This tool is a four quadrant matrix that classifies
stakeholders in relation to the power that they
hold and their level of interest in the
technology. Power classification can be based
on the ability of stakeholders to define or
influence health care systems and services,
change the way services are provided, or guide
the public opinion.
Highlights the importance of actors and
interest groups in the technology
The stakeholders interests, perceptions
positions, and influence are subject to
change
[38]
Stakeholder SWOT A SWOT analysis (Strengths, Weaknesses,
Opportunities, and Threats) can help in
understanding the interests of key stakeholders,
the actions they can take to support and the
risks that they pose to implementation of the
technology.
Can be used to stimulate and organize
thoughts and discussions in stakeholder
analysis.
Procedures for performing a SWOT-analysis
are not clearly defined.




Exploring public values and
preferences
A methodology document published by the
National Coordination Centre for Health
Technology Assessment (UK) presents the
results of a systematic review of qualitative and
quantitative approaches to involving the public
in in HTA. The document identifies and
describes details of the techniques that can be
used to obtain public preferences and makes
recommendations regarding the use of different
techniques. Some of the commonly used
methods identified in this document are as
follows:
− Quantitative techniques, including ranking
(e.g., simple ranking, qualitative discriminant
process, and conjoint analysis) rating (e.g., visual
analogue scale) and choice-based (e.g., standard
gamble, time-trade-off, discrete choice conjoint
analysis and willingness to pay) methods.
− Qualitative techniques, including individual
interviews, focus group discussions, Delphi
technique, citizen’s juries, consensus panels, and
nominal group techniques.
Summarizes and compares various
techniques in a single document.
Uses pre-defined sets of criteria to evaluate
methodological issues of different
techniques (e.g., validity, reliability/
reproducibility, generalizability, acceptability
to respondents, or cost) identified
methodologies.
Provides examples of how the techniques
have been used in research practice.
No single best technique or group of
techniques for public engagement is
recommended by this document.
Users of the tool may require background
knowledge and specific skills that enable
them to choose and conduct an
appropriate public engagement technique.
[40]
D. Identification and analysis of ethical issues
The Socratic approach (Hofmann’s
guiding questions)
This approach consists of 6 steps, whereof one
step covers 7 main questions and 33
explanatory and guiding questions. This
checklist is designed t for identification of and
reflecting on ethical data throughout the HTA
process, and for reflexive dialogue with
stakeholders.
Takes into account several ethical
perspectives and analytical approaches.
Can be used by HTA practitioners who may
be less familiar with ethical analysis.
Facilitates ethical analysis.
Users of the tool may require some level of
ethical knowledge in order to use














Table 2 Commonly used tools for ethical evaluation in HTA (Continued)
HTA core model’s assessment
element cards (AECs)
AECs describe the details of the information
that is outlined by the basic units of the HTA
Core Model (assessment elements). Each AEC
provides information on the element, its
importance and transferability for different
applications (diagnostic, surgical, pharmaceutical
or screening technologies), and appropriate
sources of information and research
methodologies to address the question defined
by the element.
The ethical domain of the Core Model includes
19 elements related to the 19 ethical issues on
the topics of beneficence/non maleficence
(4 AECs), autonomy (4 AECs), respect for
persons (3 AECs), justice and equity (3 AECs),
legislation (2 AECs), and ethical consequences
of HTA (3 AECs).
Designed to provide structured information
required for answering the generic question
defined by each assessment element.
Useful when producing HTA reports based
on the HTA Core Model.
The way in which AECs should be used as a
part of the assessment is not fully addressed
in the model.
[5]
Ethical matrix Ethical matrix is an analytical tool to aid ethical
analysis of technological options The matrix
uses a tabular format to identify ethical impact
of a particular technology on different
stakeholders. The table lists a set of prima facie
moral principles, typically the four Beauchamp
and Childress’s moral principles (autonomy,
beneficence, non-maleficence, and justice),
along one axis and different stakeholder groups
along the other axis. Relevant facts and values
are usually listed in each cell of the ethical
matrix. Ethical matrix can be used either to
identify ethical considerations around the
technology or to quantify and compare the
impact of the technology on different principles
using semi-quantitative scores (e.g., ranging
from -2 to +2).
Facilitates ethical analysis by simplifying and
structuring ethical discussion
Raises awareness of a wide range of ethical
concerns
Helps researchers and decision-makers to
avoid bias towards a specific moral principle.
Can be used in both expert-led and
participatory/deliberative ethical evaluation
processes.
May become large, complex and difficult to
manage, when too many moral principles
are listed or diverse groups of stakeholders
are identified.
[42]
Consequences table A summary table of consequences of using and
not using a particular healthcare technology is
recommended in the HTA core model as an
open framework for performing ethical analysis.
This table summarizes key benefits and adverse
impacts of implementing of the technology or
otherwise on various stakeholder groups.
A consequences table summarizing positive and
negative impacts of the technology on all
domains of HTA, along with references to the
quality of their evidentiary sources, is also
proposed as a part of the HTA core model’s
reporting template.
Allows for highlighting key impacts of a
particular technology on various domains of
HTA.
Can be used by decision-makers to compare
anticipated ethical issues around alternative
technologies in relation to other domains.














Table 2 Commonly used tools for ethical evaluation in HTA (Continued)
E. Computerized support tools for aiding ethical analysis
EthXpert EthXpert is a computer program designed to
help the user in summarizing and structuring
ethical problems, describing potential inter-
relations between the interests of different
stakeholders, and analyzing the impact of
alternative technologies on various stakeholders’
interests.
Does not focus on a specific audience or
any specific contexts. Therefore, can be
applied to ethical evaluation in HTA.
In some cases, the use of the these
computer programs can be difficult and
time consuming, especially when one needs
to include all details about complex ethical
problems, or too many different
perspectives.
The use of the software may require
investment in resources.
[29]
ETHOS Ethos is a computer program that provides a
framework for organizing, storing and analyzing
ethical information needed for problem solving
or decision-making. The program allows for eth-
ical analyses using different ethical theories and
approaches.
Illustrates the flow of data collection and
analysis in a map format.
Enables the user to add or remove













shaping of technology). It can be useful to employ more
than one method in a given evaluation to help attend to
the problem of bias, address the complexity of ethical di-
lemmas and uncertainties around healthcare technologies,
and better justify HTA decisions [14, 20–23]. Different
approaches can be compared and contrasted to more
thorough and balanced results.
Hofmann et al. describe the most frequently used
approaches for addressing ethics in HTA and provide
guidance for choosing among various analytical ap-
proaches [24]. They believe that the selection of analyt-
ical approach for addressing ethical considerations in a
specific HTA depends on the goal, context and process
of HTA. Based on their classification of different
methods of integrating ethics into HTA, the authors of
this guidance document suggest that traditional bio-
ethical approaches (e.g., deontology, casuistry, princip-
lism, and axiology) are more suitable if ethical inquiry is
performed as an independent assessment with less
(subsidiary integration) or equal (combined integration)
importance compared to other domains of HTA; while
the approaches that are developed with a focus on the
process of HTA (e.g., Socratic approach, interactive tech-
nology assessment, and social shaping of technology) are
more appropriate when there are overlapping dynamics
(coordinated integration) or continuous interactions
(interactive integration) between ethics and other do-
mains of HTA.
It is important to note that the results of ethical analyses
may be influenced by the analysts’ knowledge, their expe-
riences, values, and attitudes, as well as the technological,
organizational, social, and political contexts in which the
analyses are performed. Ethical analyses are also at risk of
bias due to actual or potential conflict of interests in the
HTA organization, such as which may influence the ways
in which ethical information is collected, analyzed and
interpreted. Therefore, it is good practice to provide a
sound justification of the choice of the methods and
disclose any financial and non-financial relationships with
organizations or groups who may have an interest in the
candidate technology and its implementation.
Step6. Deliberation
Once the preliminary analysis of ethical data is com-
pleted, it is desirable to discuss the results with the
members of the multidisciplinary HTA team, and other
experts if needed, in order to verify plausibility and rea-
sonableness of the results. To ensure that the results are
perceived as relevant by stakeholders and the public, it
is also important to use public engagement methods
to take in a variety of inputs from the groups
whose values and preferences can provide a means for a
better informed and legitimate policy decisions [25].
Although engagement of the public (including relevant
stakeholders) in an ethical evaluation process, and in
HTA in general, has been promoted at different levels,
the common exercise is to gather the public input in an
ad-hoc basis through deliberative methods such as
surveys, focus group discussions, etc. Alternatively, the
public input can be sought directly from the public
representatives who are involved throughout the HTA
process, or through an institutionalized approach, where
the public or specific stakeholder groups are asked, as
consultants, to provide input for decision-making in an
ongoing basis [25]. Despite its importance, as a demo-
cratic exercise in ethical evaluation, public involvement
methods can be challenging to perform due to their
complexity, costliness, and time consuming nature [26].
Additional expert insight might be necessary to ensure
the plausibility of the produced results during stake-
holder hearings, before a particular conclusion is
reached and the final report on ethical issues around the
technology is written.
Step7. Knowledge exchange/translation
The purpose of HTA is primarily to support healthcare
policy-makers in making evidence-informed decisions,
and secondarily to help advance knowledge about a par-
ticular health technology and stimulate further research
[27]. Therefore, the dissemination of the HTA findings,
including ethical aspects, must be timely and appropri-
ately tailored to the needs of potential users.
In order for the results of an ethical assessment to be
utilized as an input for decision-making, the knowledge
translation activities should begin in the earliest stages
of the HTA process, through an effective interaction be-
tween HTA-producers and decision-makers, and con-
tinue throughout the evaluation [28]. The results need
to be communicated in a manner that can be under-
stood and easily utilized by decision-makers. The feed-
back from potential users should be received throughout
the project and used to improve the quality of the re-
search. HTA reports should address various dimensions
of an existing or hypothetical ethical problem surround-
ing the technology of interest, using all relevant evidence
from research and non-research sources, and applying
suitable analytical approaches. It is also important to ad-
dress how different stakeholders and members of society
might be affected by the implementation of the technol-
ogy or otherwise.
HTA findings can also be disseminated among other
relevant target groups, such as healthcare researchers,
clinicians, healthcare service providers (e.g. hospitals),
third party payers, biomedical manufacturers, patients,
and the general public. However, it is essential to trans-
late the findings (including the results of the ethical
analysis) into formats that are understandable and useful
to the above-mentioned groups of audience [7].
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Selected tools
Table 2 provides a list of tools and techniques to support
ethical evaluation tasks. This list does not include every
possible tool that could potentially be used at each step of
the proposed model, but has explored some of the more
common ones that can assist HTA practitioners in evalu-
ation of ethical considerations. It is important that HTA
practitioners with responsibility for addressing ethical issues
have a comprehensive knowledge and understanding of
such tools in order to choose tools which are appropriate
for varied types of ethical objectives and evaluation tasks.
Four categories of tools can be distinguished in Table 2:
ethics literature review and appraisal, stakeholder analysis,
exploring stakeholder values and preferences, and identifi-
cation and analysis of ethical issues. We also searched for
computerized support tools for aiding ethical analysis and
identified a number of tools which were designed to help
the users in summarizing and structuring ethical argu-
ments, describing potential inter-relations between the
interests of different stakeholders, or analyzing the impact
of alternative technologies on various stakeholders’ inter-
ests. Although the selected computer programs, i.e., EthX-
pert [29] and Ethos [30], were originally offered as ethical
decision-making support tools, they could potentially be
applicable in ethical analysis for HTA.
Discussion
We believe that, only by fully understanding all of the
different steps of ethical evaluation and specific issues
that may arise at each step, can HTA teams integrate
ethics in their assessments. The framework presented in
this article outlines the important steps that should be
adopted by HTA practitioners for a comprehensive
evaluation of ethical considerations. It is intended to
guide HTA producers, especially those who are not ac-
customed to performing ethics reviews. The framework
may also be used by researchers, evaluators, or decision-
makers in order to critically appraise the process used
for an ethical evaluation; or for educational purposes, es-
pecially to show the flow of activities needed for the
evaluation of ethical considerations. Our framework may
be a beneficial addition to the existing literature on eth-
ics and HTA, for the following reasons:
Firstly, the framework is informed by the key oper-
ational features of existing ethical guidelines for HTA, as
well as practical concerns and technical demands of
potential user. It recognizes that ethical evaluations
might be discounted or not undertaken in some HTA
organizations because they are perceived as being im-
practical, resource consuming, or unfeasible. Therefore,
the framework encourages proper scoping, strategic re-
source planning, and strengthening organizational capacity.
Secondly, the proposed framework aims to promote a
more systematic and structured way of integrating ethics
into HTA by mapping the relatively complex process of
ethical evaluation and highlighting its main steps. None-
theless, it is conceptually simple and employs terms and
concepts that are familiar to the majority of HTA practi-
tioners, including those who are less familiar with ethical
evaluations. The visual representation of the stepwise
process helps HTA practitioners to understand the na-
ture of an ethical evaluation. The stepwise guide, on the
other hand, reduces the complexity of evaluation by
breaking down the procedural steps to smaller sets of
tasks and providing guiding questions. With its focus on
making the evaluation process more understandable and
practical for all HTA practitioners, the framework can
be easily used in training of HTA professionals, as well
as also being able to play a role in harmonizing existing
evaluation approaches across HTA organizations.
Thirdly, the stepwise framework accommodates the
changing relationship between technology assessment,
policy, and society by fostering the integration of stake-
holder and public input into the ethical evaluation
process. Furthermore, it promotes a holistic approach to
evaluation and stresses that ethical issues need to be seen
in interconnection with clinical, economic, social and legal
issues, and that these relationships require an appropriate
cooperation between the team members working in
different domains of HTA. Another important aspect of
the stepwise framework is its flexibility. The users of
the framework are offered the possibility to choose the
tasks that are more relevant to their assessments or to
customize the evaluation process according to their needs.
In summary, the strengths of our proposed framework
lie in its structured yet flexible approach to the evalu-
ation of ethical considerations in HTA. It can, therefore,
be helpful in building a more consistent practice of
ethical evaluation among HTA professionals.
In spite of its strengths, our proposed framework also
has limitations. Firstly, to use the framework HTA pro-
ducers may require information, data and expertise and
other resources that may not be readily available in a typ-
ical HTA organization. Qualitative evidence, stakeholder
input and normative judgements are usually required to
address ethics-related questions. Our framework fails to
deeply address the ways in which ethical data should be
tackled or specify how the evaluation process should be
applied in different contexts. Secondly, the current version
of our stepwise framework lacks an example case study
where all the steps are applied. Furthermore, the valid-
ation of the proposed framework was not performed as
part of this research project.
We will undertake further work to validate the frame-
work and test its practicality through case studies, seek-
ing stakeholder feedback, and expert opinion. Based on
the results from the case studies and feedback received
from the experts and potential users, we are planning to:
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(a) modify the stepwise framework by adding or remov-
ing steps; and (b) enhance its practicality by adding flow
charts that illustrate details of various steps, and auxil-
iary tools or checklists to facilitate the ethical evaluation
process; and (c) perform a final validation of the frame-
work using further case studies.
Conclusions
Despite the increasing attention given to the incorporation
of ethical considerations in assessment of healthcare tech-
nologies, HTA producers continue to face challenges in
integrating ethics to HTA. The intention of this research
has been to construct a procedural framework that
considers the nature and sequence of ethical evaluation
process in the context of HTA. The proposed framework
provides a conceptual foundation to allow for ethical
issues to be addressed in HTA. Our framework can serve
as a starting point towards a set of comprehensive stra-
tegic guidelines, as well as for the supporting and promot-
ing good practice of integrating ethics in HTA. However,
for a wider use and dissemination, its content needs to be
applied in various HTA projects and validated through
consultation with experts and policy makers.
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